Agenda | Kisaco Research

Agenda

2nd Annual Microbiome Connect: ASIA 2024
19-20 June, 2024
Seoul, Republic of Korea
Please fill in the form on the right for access to the PDF agenda for the 2nd Annual Microbiome Connect: Asia Congress

Book Before This Friday & Save $700!


Highlights from the program include: 

Wednesday, 19 Jun, 2024
09:00-09:30

Navigating Investment Challenges for Microbiome Drug Development: The Roadmap to Investment

  • Introduction to the current microbiome investment landscape and what direction investment is heading in over the next few years.
  • Highlighting what investors need to see from emerging companies, how are CSB evaluating companies.
  • How should microbiome companies adapt to trends and what should data packages contain.

Sou Miyake, Director of Investment & Business Development, Corundum Systems Biology

Author:

Sou Miyake

Director of Investment & Business Development
Corundum Systems Biology

Sou Miyake

Director of Investment & Business Development
Corundum Systems Biology
12:00-12:30

Using Pharmaceutical Meta-Analytical Screening (PMAS) for Personalized Microbiome Solution

  • Considerations for live-biotherapeutic development and applicability: reviewing microbiota variation, biomarkers, and metabolites.
  • Integrating a personalization approach to therapeutic discovery, linking clinical trial outcomes with in-vitro results obtained from the PMAS system.
  • How to harness the metabolome to guide the next generation of live-biotherapeutics.

Yosep Ji, Chief Executive Officer, HEM Pharma

Author:

Yosep Ji

Chief Executive Officer
HEM Pharma

Yosep Ji

Chief Executive Officer
HEM Pharma

Download the Agenda

Other events you might be interested in:

Microbiome Connect: USA 2024